Lisanti Capital Growth LLC purchased a new position in Aehr Test Systems (NASDAQ:AEHR – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 36,395 shares of the semiconductor company’s stock, valued at approximately $3,626,000. Lisanti Capital Growth LLC owned 0.11% of Aehr Test Systems at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Knights of Columbus Asset Advisors LLC purchased a new position in shares of Aehr Test Systems in the third quarter worth $2,149,000. Keybank National Association OH purchased a new position in Aehr Test Systems during the third quarter valued at $205,000. Allspring Global Investments Holdings LLC purchased a new position in Aehr Test Systems during the third quarter valued at $3,203,000. StoneRidge PMG Advisors LLC bought a new stake in Aehr Test Systems in the 3rd quarter valued at $227,000. Finally, Pictet Asset Management Holding SA increased its holdings in Aehr Test Systems by 48.7% in the 3rd quarter. Pictet Asset Management Holding SA now owns 24,769 shares of the semiconductor company’s stock valued at $2,467,000 after acquiring an additional 8,115 shares during the last quarter. 69.69% of the stock is currently owned by institutional investors.
Aehr Test Systems Stock Performance
NASDAQ AEHR opened at $65.78 on Thursday. The stock has a 50 day moving average price of $78.73 and a 200-day moving average price of $74.97. Aehr Test Systems has a one year low of $18.70 and a one year high of $147.40. The company has a market capitalization of $2.16 billion, a P/E ratio of 1,644.50 and a beta of 3.36.
Aehr Test Systems (NASDAQ:AEHR – Get Free Report) last announced its quarterly earnings results on Monday, November 2nd. The semiconductor company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.17. The company had revenue of $33.01 million for the quarter, compared to analysts’ expectations of $27.53 million. Aehr Test Systems had a net margin of 2.97% and a return on equity of 1.76%.
Insider Buying and Selling at Aehr Test Systems
In other news, Director Howard T. Slayen sold 5,700 shares of the business’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $133.03, for a total value of $758,271.00. Following the sale, the director directly owned 140,667 shares in the company, valued at $18,712,931.01. The trade was a 3.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Rhea J. Posedel sold 5,973 shares of the company’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $140.00, for a total transaction of $836,220.00. Following the sale, the director owned 381,989 shares in the company, valued at $53,478,460. This represents a 1.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 4.60% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several analysts have commented on the stock. Wall Street Zen upgraded shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a research note on Saturday, July 18th. Jefferies Financial Group cut their price objective on Aehr Test Systems from $175.00 to $140.00 and set a “buy” rating for the company in a research report on Tuesday, November 3rd. Freedom Capital upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Oppenheimer began coverage on Aehr Test Systems in a report on Thursday, September 10th. They issued an “outperform” rating and a $120.00 target price on the stock. Finally, Lake Street Capital decreased their target price on Aehr Test Systems from $110.00 to $90.00 and set a “buy” rating on the stock in a research report on Tuesday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $118.75.
Get Our Latest Research Report on AEHR
Aehr Test Systems Profile
Aehr Test Systems designs, manufactures and markets semiconductor test and burn-in equipment and related products. Its systems are used to test devices at the wafer, die and packaged-chip stages of production. The company’s offerings include FOX series test and burn-in systems, WaferPak wafer-level contactors and DiePak carriers. These products support testing for applications such as silicon carbide power semiconductors, silicon photonics and other devices used in automotive, computing and communications markets.
See Also
- Five stocks we like better than Aehr Test Systems
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
